Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)
April 18, 2024 02:36 PM EDT
Pharma
Marketing

Sanofi re­struc­tures US com­mer­cial vac­cines sales force

Nicole DeFeudis

Editor

Sanofi is over­haul­ing its US com­mer­cial op­er­a­tions for its vac­cines and will cut an undis­closed num­ber of jobs, the com­pa­ny con­firmed to End­points News. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times